What is Afrezza 8mg U30 S Cartridg+Inh (INSULIN)?
Insulin replacement or supplementation for type 1 and type 2 diabetes. Various formulations: rapid-acting (lispro, aspart), short-acting (regular), intermediate (NPH), long-acting (glargine, detemir, degludec).
How it Works
Binds insulin receptors promoting glucose uptake in muscle and adipose tissue, reducing hepatic glucose production, and enabling energy storage. Lowers blood glucose.
Quick Specs
| Form | Oral tablets — pre-dosed |
| Active Ingredient | INSULIN |
| Dose per Tablet | 8MG |
| Pack Size | 18×10 (180 tablets) |
| Storage | Room temperature (15–25°C), cool dry place |
| Shelf Life | 2–3 years (properly stored) |
Common Side Effects
Hypoglycemia (most serious — can be life-threatening if severe), injection site reactions, lipohypertrophy, weight gain, hypokalemia.
Safety Warnings
⚠️ Hypoglycemia monitoring mandatory. Carry fast-acting glucose at all times. Rotate injection sites. Doses must be individualized. Many drug interactions affecting glucose levels. Cold storage (refrigerator) required.
🌏 International shipping: 7–14 days
